# Regenesis Pharmaceutical Inc. – FDA Inspection, Jun 18, 2019

Source: https://www.keypedia.com/records/fda_inspections/regenesis-pharmaceutical-inc/394e483e-0160-4b5b-924c-97fa756a7c00
Source feed: FDA_Inspections

> FDA inspection 1093423 of Regenesis Pharmaceutical Inc., June 18, 2019. Classification: Voluntary Action Indicated (VAI). 12 citations under 21 CFR part 211. Form 483 issued.

---

## Details

- Record Type: FDA Inspection
- Inspection ID: 1093423
- Company Name: Regenesis Pharmaceutical Inc.
- Inspection Date: 2019-06-18
- Classification: Voluntary Action Indicated (VAI)
- Classification Code: VAI
- Project Area: Unapproved and Misbranded Drugs
- Product Type: Drugs
- Center: Human Drugs
- Office Name: Center for Drug Evaluation and Research
- Citation Count: 12

## Related Officers

- [Alan L. Truong](https://www.keypedia.com/people/alan-l-truong/8b9c59ed-ce68-44c3-9fbe-07cc3da13713)

Company: https://www.keypedia.com/companies/regenesis-pharmaceutical-inc/e74e384c-018e-4735-b2f2-7cf6dd27a8fa

Office: https://www.keypedia.com/offices/center-for-drug-evaluation-and-research/cd980d74-1cbf-4226-ba9a-9045324c236c